88
Views
6
CrossRef citations to date
0
Altmetric
Review

The clinical utility of aflibercept for diabetic macular edema

Pages 473-482 | Published online: 18 Sep 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Rasha Barham, Hala El Rami, Jennifer K. Sun & Paolo S. Silva. (2017) Evidence-Based Treatment of Diabetic Macular Edema. Seminars in Ophthalmology 32:1, pages 56-66.
Read now

Articles from other publishers (4)

Sławomir Liberski, Małgorzata Wichrowska & Jarosław Kocięcki. (2022) Aflibercept versus Faricimab in the Treatment of Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: A Review. International Journal of Molecular Sciences 23:16, pages 9424.
Crossref
Sylvia Josephy-Hernandez, Sean Jmaeff, Iulia Pirvulescu, Tahar Aboulkassim & H. Uri Saragovi. (2017) Neurotrophin receptor agonists and antagonists as therapeutic agents: An evolving paradigm. Neurobiology of Disease 97, pages 139-155.
Crossref
Takao Hirano, Yuichi Toriyama, Yasuhiro Iesato, Akira Imai, Kazutaka Hirabayashi, Taiji Nagaoka, Yoshihiro Takamura, Masahiko Sugimoto & Toshinori Murata. (2016) Effect of leaking perifoveal microaneurysms on resolution of diabetic macular edema treated by combination therapy using anti-vascular endothelial growth factor and short pulse focal/grid laser photocoagulation. Japanese Journal of Ophthalmology 61:1, pages 51-60.
Crossref
Jorge L. Cueva Vargas, Nicolas Belforte & Adriana Di Polo. (2016) The glial cell modulator ibudilast attenuates neuroinflammation and enhances retinal ganglion cell viability in glaucoma through protein kinase A signaling. Neurobiology of Disease 93, pages 156-171.
Crossref